Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516230/
http://dx.doi.org/10.1007/s40278-020-83699-4
_version_ 1783586963184418816
collection PubMed
description
format Online
Article
Text
id pubmed-7516230
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75162302020-09-25 Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports Reactions Weekly Case Report Springer International Publishing 2020-09-26 2020 /pmc/articles/PMC7516230/ http://dx.doi.org/10.1007/s40278-020-83699-4 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title_full Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title_fullStr Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title_full_unstemmed Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title_short Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
title_sort apixaban/heparin/rivaroxaban: melaena and thrombocytopenia: 2 case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516230/
http://dx.doi.org/10.1007/s40278-020-83699-4

Ejemplares similares